OnKure Therapeutics, Inc. OKUR Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s net change in cash?
- OnKure Therapeutics, Inc. (OKUR) reported net change in cash of $133.06M in Q1 2026.
- How has OnKure Therapeutics, Inc.'s net change in cash changed year-over-year?
- OnKure Therapeutics, Inc.'s net change in cash increased by 1043.7% year-over-year, from -$14.1M to $133.06M.
- What is the long-term trend for OnKure Therapeutics, Inc.'s net change in cash?
- Over 3 years (2022 to 2025), OnKure Therapeutics, Inc.'s net change in cash has grown at a -21.0% compound annual growth rate (CAGR), from -$104.73M to -$51.71M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.